This report provides a detailed analysis of marketing planning, specifically focusing on the launch of a flu vaccine by GSK, a UK-based company. It begins with an introduction to marketing planning, emphasizing its role in new product development and the evolving perspectives within the field. The report explores the significance of marketing planning and its impact on product launches, particularly for products aimed at specific demographics like the elderly. Task 1 delves into the changing perspectives of marketing, evaluating GSK's capabilities through financial, technological, promotional, and marketing lenses. It also covers organizational auditing using SWOT analysis and PESTLE analysis to assess internal strengths, weaknesses, opportunities, threats, and external factors influencing the business. Task 2 identifies and discusses various barriers to marketing planning, including environmental, cultural, cognitive, and governmental barriers, and suggests methods to overcome them. Task 3 outlines the steps of marketing planning, including situation analysis, identifying the target audience, setting marketing objectives, developing marketing strategies, and creating a marketing budget. Finally, Task 4 focuses on new product development, emphasizing market research, product positioning, and promotional strategies. The report concludes with a summary of the key findings and the overall significance of effective marketing planning for successful product launches.